CLINICAL PRESENTATION OF VOGT-KOYANAGI-HARADA DISEASE. CASE REPORT
Keywords:
blurred vision, headache, autoimmuneAbstract
Vogt-Koyanagi-Harada disease, commonly abbreviated as VKH, is a type of disorder that is classified as autoimmune and has a significant impact on multiple systems of the human body. This complex disorder not only affects visual health, compromising eye function, but also involves the central nervous system, which can cause various neurological symptoms. In addition, the disease has repercussions on the auditory system, which can result in hearing problems, and also affects the integumentary system, which includes the skin and its appendages. Thus, it can be said that VKH is a multifaceted health disorder that requires a comprehensive approach to diagnosis and treatment. An immune system response against antigens that are related to melanocytes, which are present in various parts of the body such as the uvea, meninges, inner ear, skin and hair, results in the appearance of multiple manifestations of the disease. These manifestations may arise at different stages throughout the evolution of the condition, thus showing the variability in its development.
Keywords: blurred vision, headache, autoimmune.
Downloads
References
Urzua CA, Herbort CP, Takeuchi M, Schlaen A, Concha-del-Rio LE, Usui Y, et al. Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. J Ophthalmic Inflamm Infect. 2022 Dec 1;12(1).
Baltmr A, Lightman S, Tomkins-Netzer O. Vogt-Koyanagi-Harada syndrome - Current perspectives. Clinical Ophthalmology. 2016 Nov 24;10:2345–61.
Betancourt R, Betancourt SA, Soler G, Mantilla RD, Castillo GA. Vogt-Koyanagi-Harada disease. Case report and review of the literature. Revista Colombiana de Reumatologia. 2020 Jan 1;27(1):50–60.
Yang P, Liao W, Pu Y, Zhong Z, Wang H, Yu Q, et al. Vogt-Koyanagi-Harada disease in pediatric, adult and elderly: clinical characteristics and visual outcomes. Graefe’s Archive for Clinical and Experimental Ophthalmology [Internet]. 2023;261(9):2641–50. Available from: https://doi.org/10.1007/s00417-023-06058-5
Joye A, Suhler E. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol [Internet]. 2021;32(6). Available from: https://journals.lww.com/co-ophthalmology/fulltext/2021/11000/vogt_koyanagi_harada_disease.13.aspx
Grupo de trabajo sobre estandarización de la nomenclatura de la uveítis (SUN). Classification Criteria for Vogt-Koyanagi-Harada Disease. Am J Ophthalmol. 2021 Aug 1;228:205–11.
Tugal-Tutkun I, Smit DP, Abu El-Asrar AM, Herbort CP, Thorne JE. Vogt-Koyanagi-Harada Disease. Vol. 32, Ocular Immunology and Inflammation. Taylor and Francis Ltd.; 2024. p. 363–6.
Ankush K, Sanjay S, Padmamalini M, Rohit S. Commentary: Dexamethasone intravitreal implant therapy in Vogt– Koyanagi–Harada disease. Indian J Ophthalmol. 2022;70:2470–1.
Li L, Yuan L, Zhou X, Hua X, Yuan X. Bibliometric analysis of the Vogt‒Koyanagi‒Harada disease literature. Int Ophthalmol. 2023 Nov 1;43(11):4137–50.
Tayal A, Daigavane S, Gupta N. Vogt-Koyanagi-Harada Disease: A Narrative Review. Cureus. 2024 Apr 24;
Hamano Y, Maruyama K, Oie Y, Maeda N, Koh S, Hashida N, et al. Novel corneal morphological alterations in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2022;66(4):358–64.
Published
How to Cite
Issue
Section
Copyright (c) 2024 GESTAR Arbitrated Scientific Journal in Health Research. ISSN: 2737-6273.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
